By Marie Rosenthal
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to recommend approval of the COVID-19 vaccine by Janssen Pharmaceuticals, a Johnson & Johnson (J&J) company, for people 18 years and older at least two months after a single-dose primary vaccination.
More than 14 million people in the United States would be eligible for the booster if the FDA follows the recommendation and expands the emergency use authorization (EUA) to allow the